Cargando…
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications
Immunotherapy has been well regarded as one of the safer and antigen-specific anti-cancer treatments compared to first-generation chemotherapy. Since Coley’s discovery, researchers focused on engineering novel antibody-based therapies. Including artificial and modified antibodies, such as antibody f...
Autores principales: | Shin, Charles, Kim, Sung Soo, Jo, Yong Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416972/ https://www.ncbi.nlm.nih.gov/pubmed/34514097 http://dx.doi.org/10.1016/j.omto.2021.08.005 |
Ejemplares similares
-
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023) -
Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy
por: Liu, Hao, et al.
Publicado: (2022) -
From discovery of RANKL to clinical application of anti-human RANKL antibody
por: Yasuda, Hisataka, et al.
Publicado: (2012) -
Discovery of an antibody for pan-ebolavirus therapy
por: Furuyama, Wakako, et al.
Publicado: (2016) -
The Discovery of Novel Experimental Therapies for Inflammatory Arthritis
por: Malemud, Charles J.
Publicado: (2009)